CSIMarket Company Name, Ticker, Customers, else..
 
Innate Pharma Sa  (NASDAQ: IPHA)
 

IPHA's Market share relative to its competitors, as of Q4 2025

As of Q4 2025 (Revenue in Millions of $)

Date modified: 2026-08-28T06:27:08+00:00




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

COMPANY NAME REVENUES
12 Months Ending
Q4 2025		 MARKET SHARE
12 Months
Q4 2025		 MARKET SHARE
MRQ
Q4 2025		 MARKET SHARE
A Quarter Before
Q3 2025
Innate Pharma Sa 10.09 0.00% 0.00 % 0.00 %
Merck and Co Inc 65,768.00 23.30% 14.82% 13.85%
Astrazeneca Plc 54,073.00 19.16% 52.43% 45.98%
Bristol myers Squibb Company 48,482.00 17.18% 10.25% 10.63%
Amgen Inc 45,369.00 16.07% 7.69% 15.32%
Gilead Sciences Inc 29,736.00 10.53% 6.21% 6.74%
54 more competitors available

Sign in to see all competitors for Innate Pharma Sa.

Sign In Create Free Account



IPHA's Market share relative to its competitors, as of Q4 2025 within the Biotechnology & Pharmaceuticals Industry
As of Q4 2025



COMPANY NAME MARKET SHARE
12 Months Ending
Q4 2025		 MARKET SHARE
12 Months Ending
Q3 2025		 MARKET SHARE
MRQ
Q4 2025		 MARKET SHARE

Q3 2025
Innate Pharma Sa 0.01% 0.03% 0.01 % 0.03 %
Amgen Inc 45.81% 40.29% 39.90% 58.41%
Gilead Sciences Inc 30.02% 35.49% 32.22% 25.69%
Biogen Inc 10.03% 11.92% 11.47% 7.39%
Argenx Se 8.48% 5.35% 8.48% 5.35%
Exelixis Inc 2.40% 2.80% 2.83% 1.94%
50 more companies available

Sign in to see all industry competitors for Innate Pharma Sa.

Sign In Create Free Account



IPHA's Market share relative to its competitors, as of Q4 2025 within the Healthcare Sector
As of Q4 2025



COMPANY NAME MARKET SHARE
12 Months Ending
Q4 2025		 MARKET SHARE
12 Months Ending
Q3 2025		 MARKET SHARE
MRQ
Q4 2025		 MARKET SHARE

Q3 2025
Innate Pharma Sa 0.00% 0.01% 0.00 % 0.01 %
Merck and Co Inc 23.30% 25.36% 14.82% 13.85%
Astrazeneca Plc 19.16% 17.87% 52.43% 45.98%
Bristol myers Squibb Company 17.18% 18.80% 10.25% 10.63%
Amgen Inc 16.07% 13.04% 7.69% 15.32%
Gilead Sciences Inc 10.53% 11.49% 6.21% 6.74%
54 more companies available

Sign in to see all sector competitors for Innate Pharma Sa.

Sign In Create Free Account



Note: Market share is calculated based on total revenue. To get a more accurate picture of Innate Pharma Sa's market divisions, geographic dispersion, segments, products, and services, visit Innate Pharma Sa's Business Segment.

The list includes publicly traded companies only. More information about the sources of this report can be found here.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.